wegovy a glp 1 GLP-1 weight loss drugs may be misused by patients with eating disorders: Study The Wegovy pill is still

These studies suggest a possible interorgan crosstalk including brain-BAT-heart that is modulated by LepR activation in the CNS, and this may constitute a novel target for therapies to protect the heart against ischemic insults

In addition to the lack of evidence, purity issues have been reported with melatonin supplements

Additionally, two of the identified clinical studies evaluate the same group of participants in a 12-month follow up study, limiting population diversity

How PlexusDx Supports a More Personalized Approach PlexusDx recognizes that GLP-1 safety in breastfeeding involves both clinical evidence (limited) and individual metabolic context (variable)